-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 SVlxQ6icg82JEhO4YoFlqzPBIupQCe7f4+T3Pu/j4NIj2002b/N+/dGtK5SKG4N9
 RYbdNkuDZQR3ZeJEwjfM9w==

<SEC-DOCUMENT>0001104659-08-079010.txt : 20081231
<SEC-HEADER>0001104659-08-079010.hdr.sgml : 20081231
<ACCEPTANCE-DATETIME>20081231094406
ACCESSION NUMBER:		0001104659-08-079010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20081223
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20081231
DATE AS OF CHANGE:		20081231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		081277505

	BUSINESS ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a08-31242_18k.htm
<DESCRIPTION>8-K
<TEXT>

<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;text-autospace:none;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

</div>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED
STATES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES
AND EXCHANGE COMMISSION</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of the
Securities Exchange Act of 1934</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of
earliest event reported):&#160; <b>December&nbsp;23, 2008</b></font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BIO-key
International,&nbsp;Inc.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its
charter)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other
  jurisdiction of incorporation)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-13463</font></b></p>
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File Number)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">41-1741861</font></b></p>
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer
  Identification No.)</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3349
Highway 138, Building D, Suite&nbsp;B</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wall, NJ
07719</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(732)&nbsp;359-1100</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number, including area code)</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box
below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction A.2 below):</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule&nbsp;425 under
the Securities Act (17 CFR 230.425)</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under
the Exchange Act (17 CFR 240.14a-12)</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under
the Exchange Act (17 CFR 240.14d-2(b))</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under
Exchange Act (17 CFR 240.13e-4(c))</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;text-autospace:none;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900195\08-31242-1\task3284403\31242-1-ba.htm',USER='C900195',CD='Dec 31 01:32 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 7.01&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b>Regulation FD Disclosure</b></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;">&nbsp;</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On December&nbsp;23,
2008, </font>BIO-key
International,&nbsp;Inc. (the &#147;Company&#148;) issued a
press release containing a letter to its shareholders. &nbsp;A copy of such
press release is attached as Exhibit&nbsp;99.1 to this Current Report on Form&nbsp;8-K
and is incorporated herein by reference in its entirety.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The information,
including the exhibit attached hereto, in this Current Report on Form&nbsp;8-K
shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to
the liabilities of that Section, nor shall it be deemed incorporated by reference
in any filing under the Securities Act of 1933 or the Exchange Act, except as
otherwise expressly stated in such filing.</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;text-autospace:ideograph-numeric ideograph-other;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item&nbsp;9.01&#160;&#160;&#160;&#160;&#160;&#160; Financial
Statements and Exhibits</font></b></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:ideograph-numeric ideograph-other;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;text-autospace:ideograph-numeric ideograph-other;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits:</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:ideograph-numeric ideograph-other;">&nbsp;</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-autospace:ideograph-numeric ideograph-other;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Press Release, dated December&nbsp;23, 2008, issued by
the Company</p>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:ideograph-numeric ideograph-other;">&nbsp;</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:ideograph-numeric ideograph-other;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:ideograph-numeric ideograph-other;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C900195\08-31242-1\task3284403\31242-1-ba.htm',USER='C900195',CD='Dec 31 01:32 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-KEY INTERNATIONAL,
  INC.</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:
  December&nbsp;31, 2008</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in .7pt 0in .7pt;width:3.32%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:46.68%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;/s/ Michael W. Depasquale</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in .7pt 0in .7pt;width:3.32%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="46%" valign="top" style="padding:0in .7pt 0in .7pt;width:46.68%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael W. DePasquale</font></p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in .7pt 0in .7pt;width:3.32%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="46%" valign="top" style="padding:0in .7pt 0in .7pt;width:46.68%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Executive Officer</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900195\08-31242-1\task3284403\31242-1-ba.htm',USER='C900195',CD='Dec 31 01:32 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:ideograph-numeric ideograph-other;">&nbsp;</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:ideograph-numeric ideograph-other;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT INDEX</font></b></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit<br>
  No.</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="91%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:91.02%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="91%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:91.02%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.0%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="91%" valign="bottom" style="padding:0in 0in 0in 0in;width:91.02%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press Release, dated
  December&nbsp;23, 2008, issued by the Company</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900195\08-31242-1\task3284403\31242-1-ba.htm',USER='C900195',CD='Dec 31 01:32 2008' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a08-31242_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>

<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p align="right" style="color:windowtext;margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.1</font></b></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-weight:bold;"><img width="180" height="104" src="g312421mmi001.gif"></font></b></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Press Release</font></b></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key Issues Shareholder Letter</font></b></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WALL, N.J., Dec.&nbsp;23
/PRNewswire-FirstCall/ &#151;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dear Shareholder:</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thank
you for your continued support of BIO-key.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As
we conclude what we believe will be a very strong year, we want to take the
opportunity to provide you with a preliminary business update for 2008 and
business outlook for 2009.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2008
has been an important turnaround year in BIO-key&#146;s history. Revenue is
currently projected to grow more than 20% over 2007 and we expect to achieve
profitability in the fourth quarter and cumulatively for the last nine months
of the year.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We
see this positive performance continuing into 2009. This optimism is grounded
on our growing pipeline of marquee customers:</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> We announced earlier this year a major contract
with Sagem Morpho, where we are &#145;fusing&#146; our BIO-key matching algorithm with
Sagem&#146;s to create the most accurate, high performance solution for finger
identification in the industry. This fused offering will be utilized in a
number of government programs including the upcoming FBI&#146;s NGI IAFIS
opportunity. Equally important to BIO-key and our partnership is Sagem&#146;s
position as the world&#146;s leading fingerprint-matching provider. Together we will
be well positioned to compete for large scale identification opportunities
around the globe.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> As a result of the successful completion of the
Bangladesh voter registration project, our customer, Major General Shafiqul
Islam was presented with the Outstanding Achievement Award by the ID World
International Congress held in Milan, Italy on November&nbsp;18, 2008. The
General won the award in recognition of his leadership during the Bangladesh
government&#146;s successful completion of its Voter Registration Project in
preparation for the December&nbsp;29 general elections.</font></p>

<p align="center" style="color:windowtext;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="color:windowtext;margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900195\08-31242-1\task3284403\31242-1-mm.htm',USER='C900195',CD='Dec 31 02:12 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="color:windowtext;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Senator
John McCain in his recent visit to Bangladesh on Wednesday, December&nbsp;3,
told reporters at a press conference in Dhaka&#146;s Zia International Airport, &#147;It
seems to me that with the incredible registering of 80 million people, this has
the possibility of being the fairest election, perhaps in the entire world.&#148;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> McKesson has deployed BIO-key&#146;s biometric
technology in their new automated medication dispensing cabinets. &#147;The
Connect-Rx integrated software platform surpasses all industry functionality on
the market today,&#148; said Dave Souerwine, president of McKesson&#146;s Automation
Solutions Group. &#147;It&#146;s viewed by industry experts as at least two generations
ahead of competing software solutions. Connect-Rx provides the foundation that
hospitals need to deliver safe, cost-effective care, and enables hospitals to
maximize their investment while improving safety and workforce productivity.&#148;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> Perhaps the leading technologist in the medical
industry, Dr.&nbsp;John Halamka, Dean at the Harvard Medical School and IT
Director at Beth Israel Hospital said in his December&nbsp;blog, &#147;my cool
technology of the week is the Bio-key fingerprint biometrics authentication
system, an authentication solution that is my favorite candidate for two factor
authentication, such as will likely be required by the Drug Enforcement Agency
for e-prescribing of controlled substances. Simple to implement,
standards-based, and easy to use biometric authentication &#151; that&#146;s cool!&#148;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> Other recent orders were received from AT&amp;T,
BNP Paribas Financial Services, Brand New Technologies in South Africa,
ChoicePoint, Pulaski County (IN) Sheriff&#146;s Office, Bexley (OH) Police
Department and Hawaii County (HI) Police Department.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We
believe these new awards along with our recurring maintenance revenue will
enable us to grow and be profitable throughout 2009.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our
overall plan is to fully develop our high margin strategic businesses and
opportunistically exploit certain assets to generate sufficient cash to fully
redeem our preferred stock. We believe that market conditions will improve in
the second half of 2009 and that, when combined with our anticipated solid
operating results will offer the company additional flexibility.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We
also believe that we will generate sufficient cash such that under certain conditions
the 2009 preferred dividends could be paid in cash and thus would have the
potential to eliminate the dilutive and selling pressure effect on the stock
coming from the payment of millions of shares of stock to service the preferred
dividends.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We
believe our solid 2008 performance marked with growth, profitability, solid
sales pipeline and high quality large footprint partners as customers and
references</font></p>

<p align="center" style="color:windowtext;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="color:windowtext;margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900195\08-31242-1\task3284403\31242-1-mm.htm',USER='C900195',CD='Dec 31 02:12 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="color:windowtext;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">makes
us well prepared for continued strong results in 2009.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All of BIO-key wishes you
a Merry Christmas, Happy Holidays and a prosperous New Year.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sincerely,</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael DePasquale</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CEO</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;text-indent:.6in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key Safe Harbor Statement</font></b><font size="2" style="font-size:10.0pt;"><br>
Certain statements contained in this letter to shareholders may be construed as
&#147;forward-looking statements&#148; as defined in the Private Securities Litigation
Reform Act of 1995 (the &#147;Act&#148;). The words &#147;estimate,&#148; &#147;project,&#148; &#147;intends,&#148;
&#147;expects,&#148; &#147;anticipates,&#148; &#147;believes&#148; and similar expressions are intended to
identify forward-looking statements. Such forward-looking statements are made
based on management&#146;s beliefs, as well as assumptions made by, and information
currently available to, management pursuant to the &#147;safe-harbor&#148; provisions of
the Act. These statements are subject to certain risks and uncertainties that
may cause actual results to differ materially from those projected on the basis
of these statements. These risks and uncertainties include, without limitation,
our history of losses and limited revenue, our ability to develop new products
and evolve existing ones, the impact on our business of the recent financial
crisis in the global capital markets and negative global economic trends, and
our ability to attract and retain key personnel. For a more complete
description of these and other risk factors that may affect the future
performance of BIO-key International,&nbsp;Inc. (OTC Bulletin Board: BKYI), see
&#147;Risk Factors&#148; in the Company&#146;s Annual Report on Form&nbsp;10-KSB for the year
ended December&nbsp;31, 2007 and its other filings with the Securities and
Exchange Commission. Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date made. The Company
also undertakes no obligation to disclose any revision to these forward-looking
statements to reflect events or circumstances after the date made or to reflect
the occurrence of unanticipated events.</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contact:<br>
Bud Yanak<br>
732-359-1100</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="color:windowtext;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#169;
Copyright 2008 by BIO-key International,&nbsp;Inc.</font></p>

<p align="center" style="color:windowtext;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="color:windowtext;margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900195\08-31242-1\task3284403\31242-1-mm.htm',USER='C900195',CD='Dec 31 02:12 2008' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g312421mmi001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g312421mmi001.gif
M1TE&.#EAM`!H`/8``/S__KN[NUI75^AK;;Z^OO_\_F=E9O#N\?.UMJVKK.`Z
M/OOFY^`Z0/C:V_WR\MXY/>535B0@(?[_^L?&QNR$AP```/&;G<[.SOO__.-&
M2M74U/;.SN`Z/!$1$^/BX_O__DQ)2N_O[_7!PWY^?NIX>?*HJIZ>GN=?8G!P
M</'P\)".CN(Z.M_?WXZ.CH6!@N(Y/N^<G_;-T?_]^^(Y/"(?(,C&QT!`0/G-
MSI*/C^IK;____^4X/N$[/3$M+O+L[OW]_\G'R=?4U9"0D.#@X>V1DR,>'B`@
M()&0CCX[/'5S=.5@84!!0CU`/_[^_O_^__[______?[^_/[^_^,Z0/_^_/[_
M_>,Z/?W]_?_^_>$X/)^<G<?'Q^,X0.(X0/#R\G]_?Q$1$?3!P-#.T>^$A_C`
MQ8^/CX!_???`PJ^OKY^?GU!03]\[/.,[.^_Q[F!@8/"HJ;^_OU]?7T)`0L;(
MQT!`/LC'Q<"_O3`P,-I<7P\0$@\/#^MX?A`0$,_/S]#.S]75V"'_"TU33T9&
M24-%.2XP&`````QM<T]035-/1D9)0T4Y+C"`\B]6F@`A_PM-4T]&1DE#13DN
M,!@````,8VU04$I#;7`P-S$R`````T@`<[P`+`````"T`&@```?_@#J"@X2%
MAH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^@H:*CI*6FIZBIJJNLK:ZOL+&R
MLY@`3TU04%$Z!4TZM@!.B4U.3P`ZMSI-RX.[M,^BO5`Z3L)2Q\K$U(A14+[*
MPE'?ME)2T.>?MTZ]MM.V3DT%O\OT]#H_3U(%\$_>QE!4IJ$;N$G*$V/$G)2+
M9RL9H@+R!#T11LC8-H(8+6%1J,R;+R=5@AV#5\^>,F7ROLG[P4M@QI>1NGUC
M)@47%7#.#O7R]419LHA-<L(<Z@B@#G-1G#C8`(-(CA,*HDJ=FF'`'@LB&DCP
M9DZ7-Z)@&>T+UJ#$'@@,.,S@T>7%U+<\_UY,><%#`=L!%C;(^,`K;,9N^VHF
M,T?ER0=X3D100*N`P=RZC17,L&*WL@(."J9,D8QYKF,&)!`X@'<4"@`H%.51
MJ2*EF-]4U7Y%$><$P(^;R180@5"7@Q4K#^RZG3'C`8.H<CEPJ,L#LUO'RN/6
M7<&`P@8GTPK8TE&%HB\H,EZC*L!7G`Y=W8X6V#"@KI4L#(YKYI&EKESZ\JOF
MR#%@P/ZG#*PQ@P)N7;9&5`R<@,!IU!P6##4AB8=*4KGH\`$43^P3!0(0P&?7
M6EQ8@=D,F'5AEQ(4O+'!`O+<8A`48P$`0!4Q(&!!#AG4-\4,72P'`0*%),72
M-Q*6XL1A"6%7!?][!FZ&F51U=3%#!A2(L(`$5-3D"P#[(%,%:LH$=)X@392E
M1')1<3!``U\!L)H34?14)"E2R`"%0<@X0,(4;!W'`0-LO8"9%52*($$Y"O4D
M#!5;.E'8+U7$>1IVP<@#P`(EG+"95$0X8)$Z1,X9"D6EE9!!?#-,P<!::DT1
MG()5E"9!$ZTI=$P3`+0617<2/6%G;14"L"MY3FQ`05T!GM``,D%E*.HH`$WD
MP!Z-<;`&%P(^*5D.&PPRC2_[\,4H7P5\68`45<A3P$3O/.B/L!CJL``%7#"'
M`"[A/*L),3*"2>M1#620IEVMKF%%%R=LD*$_0A72"S6[?F<0G$=Q24S_/L*`
MBEH#.1#(`P6^?"#!+SI$@8V^DL1[#3+N(&#%"ZO6]<!FCF4`@R^X$B.%2X4`
MT$05&`0CS,48XKK.00IUM?,Q@@&`0`;+D>#`((P64'1$*#M"15(*,7H+!:L"
MR@$7*RA@15H#++`E-59_=<A7,OV\3#$!W:G0S]78J4O)"J$&@)YVG3"U:2EE
M&&O6CCP1)S&Q4C'&JFL]P-QE6;RA'C%=<IF(:_;06HPPB#6AN#>!40&/:4]@
MX<O.,/`PA1(.[%.;#E1HA[@CZZ)K.`67=<$6#VPT9@4$#5R!S"[%..O:(7"^
M4W(N1DL1@P44[*<$`_T-``,":C]_S<[RA`$U_PG&Q"G#[+<[$ALQ8&_6Q<P>
M\R#X3<S(4%@YO/!UB/[$B-Z:!`@@`0/H,CG)Q(5$#(``$18PD=;LXR8!8P`1
M:+>SB:6/$<&0@10`R`;EI&H-=9E"%Z3FI?,\2%&W2L0^<E$3!\`@`SQX0%MX
ML(:J$,$",,@A$08@L%110&WY(`P4`C:#,-CM%SR[X"&2<J$-F$@!74@+`[(P
MA350P%G\XL7IG&$.;J`0"F_(P(%6Q8$3O*$!YPH*%*I@O&5@Z@0\D.#4?&6.
M,CT@`POX137DI$1298,0#H#A@.*X%A$I@1FA*@F9$(DS<`3%"0M0`A<:$QP*
M-.!+?-S?D>:E`&41R_\U")C"`*!@/%XI<9&"H$@5\C&`QI`HCCM*D`,\0J8_
M,C(;.&OD1,ITJJC,(`<-<,+(^H*(8,0*.PU00@:T(HQ@2(`",SA#4IAQ2I\L
MDE90*`&)S/:"%QQ(`7A<UTD:28A<DA.159!`P`@DF3?L0G0W202&:H(,GT6!
M`LO4@?&$X0`(0*`GH:HF-041R`)]B`<#"L-YZ'G.032AC0X=)S4"Z:0,7,="
ME*K"X0SQ+U+R(BDZ6(P#I'"8VFR`!R7HSLD$6I)C*6"2EW'/!(OAC$;.Q*'D
MQ&50*.`;NP1S(G=;I1\)H:%8X2]#3J``";J!(5TL!B0-NUW_3+*`WTFFFY?_
M@8`#P@.G6W;NJS:5".]>,`,$*(Y?`,4.(GK2P)ZDYP<..,$-SF6Z2TT!`>L0
MJ$37P5,:;@9;=D&`U08:T882"9$=<2$>1'"^7V0H"BE1A#EJQ=9I+"D'13.F
M4GU6S5J"RP&^DYQ;XJ(`"!3C`WTH`PILP%H;?`$.1`H!`>`PV]G"EI%2Z(,6
MOL"$)2S!#&A8G0[LM-)R`B0$:1B!'V@5D2>D32$CBT(#&."`C5Z0&)#=!1A'
M1!\>U&4-"&"!&_)0@?*:U[QWZ(,OU'!>\YK@CV4P0GO-RX<1G.2^AQ`O'\K[
M!;Y-0PIG0,#(*-8$)0BV$%\=YTRH&=!S+`,AM>--_Q=<%4>W0``*>ICO?/70
MARN@8+Y\@*T.0G`'#;?W#B$@+(+E:][^BFXL(35'2*I1`@I(-*RYE*B.,7(:
MT0FS`<H!E-D:\X(22`$,Y^U`<)&;X?(:01DA."\*OD'B\QK!!'"`0PM87%X4
MX]<07]@O?S]RJ*/<P$O8D4(D:ZG@D[31ICG^2P%,5Z<22(4!!\L"9190!1;0
MP+Q+R&4+SBOB\[I8!^PUKQN,-\XXG%<-#8XH&EH,(6ST8Q?Z\!D4(.`S7[Q9
M$!!5Y'TC#8V@1*$F)1`4)3>SAE%*X0IT,*\-[LN"\Z9!$(;V!1S..^O#"F()
MA!Z&#G8]YEO5AJ1YI<T5QO^P+%\SDL%7(!*C,Z*KHRP@BC2$*1YSU818E]<&
MN1S">8.K`T,+(M'E94%.?4&`\\9!V,2NP!>:D*5=6&T>]10&##:`8\^V&;&D
MID4P=N;CIU4F@<OJQQ.88%XFW-<$Y[V`,LYKWRBC%\X.Y3(8`MZ$>,^;.\9(
M!MV$VX!EV?*/J-0IFS$2J=I@AU9+P:$(A'IL.<@Z&W`0<P5Z7>X6-V'2YITR
MRA'IAF`?0M<^[P,<[$!;,50!%SHX@`G,H`8WE$'=(:!MEF>K#!9DF;;JW<(6
M$)NU)@#[VV6P`9<KX&5<^_P+MM8QD>!NWC28TY8>C[=YU=N$-.@\Z.@V;PMT
M8(/_]KH!!"!0P9>?Y8O"E_?OCY=X-BBN@Q$8'94XT_L(!HK8=I=W!"Q8NQJ4
MD8;S0O[O(6["%Y#\;0$8X/4Y%14S'+_S$K<7#+>>^-O/2X"[-U+O'[^Q,CS>
M!$>S/03*\'QY@]L'G<.!R^1N`L3EW80@@$```3`)XY5!>W`W@04F^#NYS4WW
M\L*6T9W3@?*I?TLRQ7L$I:^`$9"_WJ"?Q/85($#YW7"21+.`S;$G*L;3?;5T
M`5:F>_RE`^57`>0F?*IG:Q\&>160!LIG>QPV$^?5!R.&;GP0`B'09!7P?[56
M`9`V:OI4=MPG:PM6=.;U?[D&=`EX6+G$@N9'>^UE`WI7_UXEZ`M]<%Z5IW,V
MH&XZ\&$):'D5``?EM'B,UP0$:`\+2``]]WDZ,()=UDCHYPMKAV@FA@+K5W<X
M=U[XQP<FD$M4V('R]628IX1SL@P$.$Y&:'Y-D&M-@'\A>'>"L'YNT`2R95M?
M1P"R15\1=X<@]@7(=X+*0(.))@0*EA!J."?=EV,T6`'J96Y]]V@GUWB$1FI(
M]WFT-W\(*&^@)WSJ-U\AP!<.$`,;<$E8@S*^@'\\-V(Z]V1QZ'.^T`/GU0+:
M%XFCIXD=UV(AH'.CIX7EE8>X]`4VT(!TZ`:G80$PI!P0(`(4HR]-D`(@6`%Z
M<%L70(=EH$]2E@TL\'?'&`(LD/\&=.AEFCALE*9YZ.AS.M`'CF=?RQ!_Y44`
M3T`$R,$GEQ$&7<1X/6ABAG<%879BDG<!:V=BYJ@(\45?>;B`:M`'D7A[%S`3
M+/9D&T!6OF$<"O``)!`>68,&!=E>?/!Q-EAW.!,"1*AA(5F(BM`$K)>!3$A^
M&F8$&CA.++B-)'`@?W(V7;`"`["/2SAL+>`&K<5:;I`&A?A](_`%2?D%7Y`&
MH39B9:`&-L`'1&F4RA!MBZ!_23D"\"<((=`"2YEB4R@$4FD#;H`&-_:+Z>8`
M<]$8!_0"5D`!0_63Z$<F$,51`'>)&(=+B!!6.`5J^'53PD>$HV<!("074,(`
M8;"*4H7_>627<D/'#--F@BJ&8.?D;"N72#C3CPSH!!#P)\C1'`ED71>T!30`
M!"I``QK@!#2@`D)``T40`:V)`S1``Q%0!#J0FK!I`%ZP!46``P"``P+@"T$0
M`4F@`Q-0F[*)`[09!5Z0!$90!`*@`3H@`$B0`LFY!;<``C20`LH@`#C`$Q*`
M`8(@!;9G!%"``":"4`0R(`R``/%R2A,0`1-`FR!0`#1P!!Y0`XA7`QY0!C2P
M!34P!TV``R!0`R80`2U@FD7@`2H@`,J0!+69`KV9!`?ZGT7P!"Y``R80`#T@
M```@`#30`C5`GT]0G#2@!;X@`(KG8X1QDF703]<R`S$3%1DP_QISB3@U4`0U
M@`,]D*(T4`9P(@`"@!IE()T"X`)/4`9(<`0N4`0)D)S260;#F0(]8``I>AY4
M>A"I69T&<!2IB04"\*-:P*--D`17B@3+`)ZIA`T%<%X^``/+`2B`L@:2`P-.
MP!+55`,!^J`&T`,1<`2M0:3&@P-%H`(XD``%V@-(8`1)T`2F^:1(`*$)4`1H
MJJ8Z0*4%$`6T604"D`1?`J#5Z0)(`*@U8*77%P%`<`4L*@BQ(B,%(`1,B08-
M@"QK0#.I<J.1XI/IDYW"::6M:0Y$B@PJ$`&*8PL/6@4@T`/[20,U8``1`*'+
M*@#<N06Y6:0%4`81H`-_J@$I``)(X/^I.!``M3D!"1"M8YH$3M"J\D`J_.($
MFK*36,4!4Y`%,*`,FG-*IKD%0@"A6D`#./`+1+HN*F`$L$F?PJD#?T`#!E`'
M`>H!'^H!6=H$/9`$!7`$`F`.`.H$&H`$$1`!/1``!<"B!8"E6V"=ZR"A*2"B
M!ANP#'$/4$`$S1$5S-$<%Q8,SG)**7"J'A`$@C`!'D`,0:`!YN`!6U`'0#`!
M*>`!&E``$A`$-=`&=>`%4J`!09`"6Y`"OF"U4.`!?X`='C`!$E$'$^`%PA`$
M0;NS6!NT.H"U*:`!-;`%0(L8IY:>:0%%,!,7Q[$!8`(FIY0A'^%0'^!"`M:N
MAU(,54`!`R#_8!/Q=-<D",=@-5+@`#OD'_X!`Q(`77<2N)$[#[B2#9^3#]3@
M1*O"3@JP!E)RKW/CN)W%/%``1T`B`:E3#?+0`"?0!1```PNP*+2S2EQ2.SI`
M!A1`%UQ@(B_0*?W0'9692E\B.M3P6,<```'#:JXC.1SP`@,@"!2B#:W;,]/0
M`%$A6,($+.T:1BLP!1!``MNS`>R[`24``P,@-G&T'#]T%'*S,U%%"",1!>09
M3U(PO?1*KP]@!2`D.,)R$+$2<']K.NE9%PB`/!/Q`1%"!0AP/=U%%YD!/]XD
M%PJ41TWP`R_W"^>""'MS#(UK(56``#%TMW;A.N#4`#_@#<70!.39_[T.<VDA
M11D(<`VJ@QU(@RL+@`"*RP`#K!9_<@(D4`(-X#-<$BGITA%/$$^&`%"*LT+R
M8`$D8B(O`QP\P`7YA`%),2E)9,.FX0N[`$T*,%.WD`\WT1K!,!L^IBC]0#(/
MHT7)(PX[LU:WT,:GY@`#\"2](1G'L4QV(PQ(<B<V'"0GD0^\8P4#4%W@D`\M
MUQ-2$!`R,7"XP#7T=%;-)+IO4R[T)`4B(#!$_!L'Q0#+M`Z^6PS!\`&99,/G
M(S?V1`%94$-G8`SE0%RS@3^!<2&TXL:Z<`M>8;]8D!YOLTJH`3@[0J_-807(
MHBRL<1Y;H6DOELB$@!T0P2[UV)YITQ,C#/\/#/(-'$$;2&,,A</*#F$(Y``%
M+T2C=K$#D1%%HA0[1W$0R,`.BO/*ULQ13_,`7/`"/Q0G*/$E1W(4?:$/ZL`L
M<T,>/$$-DR+"=L,AC;$#RA$54T#`:0$#VTL[^RP)N/"_)X`9'+`#/_1J`R</
M=O(E_H(-,@(NQO81K,S*#F`!$+`6IUM%7;`&8K,"Q&-O$D`>>]/1CX`:O4"Y
M=_LRB]M893P2-=$:J>1C;H*SK!PQ&2*\:3*S!-(%]5(<#&`!PJ+*<5Q<0KT(
MIS8Z'(.Z,01.%"`:*G$DC@MP>17.3U`%#G`&^+0&]'JZ#)#3;B$YQC$&"W`:
M.R,!P4`,AS'6CG#_#*@1Q?W`(7MM!0,B("=`!`C`3+B"&HAE)Q,A`1N``$1P
M`GZR!H>Y`J15'/8Q`#=P3#.\+E#'((C-"+7Q=)N:#YG+(9)S&=YT&0,"`5:!
M0S@$`Q80W'LP`!"P&9#AS.XY,R^PGEUP,)9TS[5A$27U4!?QVHIP$[V`,=-@
M,E$@`B30&`)"&0.4&9,1%514&2`40\Z,&<<]`Z-E-@^0N[OK-7/]%0%A&-'+
MJ];]-@;A#.JP+N>R`&\`VB0R'-KB7>]-(,L!&9E!(,9MHQ00`_1F,OZ3"QQ1
M,L&`&DZ]WYE0`$&\&+X1,\?1')N"CY-S(";"!@R0`Q;0`%1P0N+$X:@PSQ'K
M\@,+<`86,-P[$AEKL<*.D54Y0-E:`4^DX\WZ+..B0$VZP!/!0`4Q<`/L"^51
MO@$.\"^K(1((@0R-B.2CDD;0<QX;,7`GX=0'$0^,<A1YM0^LO>5<_@FB<PL?
MD3L2H1U'4N;WE2$S8@NL+2>?TN:GD&-!$2G(<SHO7L_X"E3WL,;9(-9^'@HI
MU`P<@<-2L`NY4D=!037>P"6K>`4YVNB<0"I+O@PRK"X]\<8P4ESVG#P200T*
;[.FN_NJP'NNR/NNT7NNV?NNXGNNZ/A2!```[
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
